Bioprosthetic Aortic Valve Thrombosis and Literature Review
Abstract
1. Introduction
2. Case Description
3. Discussion
4. Conclusions
5. Limitations of the Study
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Abbreviations
AT | acceleration time |
AV | aortic valve |
BAV | bioprosthetic aortic valve |
CCT | cardiac CT |
CW | continuous wave |
DAPT | dual antiplatelet therapy |
DVI | Doppler velocity index |
EACTS | European Association for Cardio-Thoracic Surgery |
EF | ejection fraction |
EOA | effective orifice area |
ESC | European Society of Cardiology |
HALT | hypoattenuating leaflet thickening |
INR | international normalized ratio |
LV | left ventricle |
MG | mean gradient |
NOAC | novel oral anticoagulants |
RELM | reduced leaflet motion |
SAPT | single antiplatelet therapy |
SAVI | surgical aortic valve implantation |
TAVI | transcatheter aortic valve implantation |
TEE | transesophageal echocardiogram |
TTE | transthoracic echocardiogram |
VKA | vitamin-K antagonist |
References
- Pislaru, S.; Hussain, I.; Pellikka, P.A.; Maleszewski, J.J.; Hanna, R.D.; Schaff, H.; Connolly, H.M. Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: Lessons from a case series. Eur. J. Cardio-Thoracic Surg. 2014, 47, 725–732. [Google Scholar] [CrossRef] [PubMed]
- Naser, J.; Crestanello, J.; Nkomo, V.; Luis, S.; Thaden, J.; Geske, J.; Anderson, J.; Sinak, L.; Michelena, H.; Pislaru, S.; et al. Immobile Leaflets at Time of Bioprosthetic Valve Implantation: A Novel Risk Factor for Early Bioprosthetic Failure: A Novel Risk Factor for Early Bioprosthetic Failure. Heart Lung Circ. 2022, 31, 1166–1175. [Google Scholar] [CrossRef]
- Baumgartner, H.; Khan, S.; DeRobertis, M.; Czer, L.; Maurer, G. Discrepancies between Doppler and catheter gradients in aortic prosthetic valves in vitro. A manifestation of localized gradients and pressure recovery. Circulation 1990, 82, 1467–1475. [Google Scholar] [CrossRef]
- Roslan, A.B.; Naser, J.A.; Nkomo, V.T.; Padang, R.; Lin, G.; Pislaru, C.; Greason, K.L.; Pellikka, P.A.; Eleid, M.F.; Thaden, J.J.; et al. Performance of Echocardiographic Algorithms for Assessment of High Aortic Bioprosthetic Valve Gradients. J. Am. Soc. Echocardiogr. 2022, 35, 7. [Google Scholar] [CrossRef] [PubMed]
- A Naser, J.; Petrescu, I.; Ionescu, F.; Nkomo, V.T.; Pislaru, C.; Schaff, H.V.; A Pellikka, P.; Connolly, H.M.; Egbe, A.C.; Pislaru, S.V. Gradient changes in bioprosthetic valve thrombosis: Duration of anticoagulation and strategies to improve detection. Open Hear. 2021, 8, e001608. [Google Scholar] [CrossRef]
- Søndergaard, L. Does Subclinical Leaflet Thrombosis Impact the Durability of Bioprosthetic Aortic Valves? JACC Cardiovasc. Interv. 2022, 15, 1123–1125. [Google Scholar] [CrossRef]
- Chakravarty, T.; Søndergaard, L.; Friedman, J.; De Backer, O.; Berman, D.; Kofoed, K.F.; Jilaihawi, H.; Shiota, T.; Abramowitz, Y.; Jørgensen, T.H.; et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: An observational study. Lancet 2017, 389, 2383–2392. [Google Scholar] [CrossRef]
- Makkar, R.R.; Fontana, G.; Jilaihawi, H.; Chakravarty, T.; Kofoed, K.F.; De Backer, O.; Asch, F.M.; Ruiz, C.E.; Olsen, N.T.; Trento, A.; et al. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N. Engl. J. Med. 2015, 373, 2015–2024. [Google Scholar] [CrossRef]
- Egbe, A.C.; Connolly, H.M.; Pellikka, P.A.; Schaff, H.V.; Hanna, R.; Maleszewski, J.J.; Nkomo, V.T.; Pislaru, S.V. Outcomes of Warfarin Therapy for Bioprosthetic Valve Thrombosis of Surgically Implanted Valves: A Prospective Study. JACC Cardiovasc. Interv 2017, 10, 379–387. [Google Scholar] [CrossRef]
- Egbe, A.; Pislaru, S.V.; Ali, M.A.; Khan, A.R.; Boler, A.N.; Schaff, H.V.; Akintoye, E.; Connolly, H.M.; Nkomo, V.T.; Pellikka, P.A. Early Prosthetic Valve Dysfunction Due to Bioprosthetic Valve Thrombosis: The Role of Echocardiography. JACC Cardiovasc. Imaging 2018, 11, 951–958. [Google Scholar] [CrossRef]
- Egbe, A.C.; Pislaru, S.V.; Pellikka, P.A.; Poterucha, J.T.; Schaff, H.V.; Maleszewski, J.J.; Connolly, H.M. Bioprosthetic Valve Thrombosis Versus Structural Failure: Clinical and Echocardiographic Predictors. J. Am. Coll Cardiol. 2015, 66, 2285–2294. [Google Scholar] [CrossRef]
- Vahanian, A.; Beyersdorf, F.; Praz, F.; Milojevic, M.; Baldus, S.; Bauersachs, J.; Capodanno, D.; Conradi, L.; De Bonis, M.; De Paulis, R.; et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Hear. J. 2021, 43, 561–632. [Google Scholar] [CrossRef]
- Otto, C.M.; Nishimura, R.A.; Bonow, R.O.; Carabello, B.A.; Erwin, J.P., 3rd; Gentile, F.; Jneid, H.; Krieger, E.V.; Mack, M.; McLeod, C.; et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Thorac. Cardiovasc. Surg. 2021, 162, e183–e353. [Google Scholar] [CrossRef]
- Imamura, E.; Ohteki, H.; Tsutsui, T.; Nishiya, Y.; Ishihara, S.; Koyanagi, H. Open versus closed position fixation of bioprosthesis. Comparative in vitro studies from the viewpoint of durability. J. Thorac. Cardiovasc. Surg. 1982, 83, 755. [Google Scholar] [CrossRef]
- Lancellotti, P.; Pibarot, P.; Chambers, J.; Edvardsen, T.; Delgado, V.; Dulgheru, R.; Pepi, M.; Cosyns, B.; Dweck, M.R.; Garbi, M.; et al. Recommendations for the imaging assessment of prosthetic heart valves: A report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging†. Eur. Hear. J.-Cardiovasc. Imaging 2016, 17, 589–590. [Google Scholar] [CrossRef]
- Raschpichler, M.; Flint, N.; Yoon, S.-H.; Kaewkes, D.; Patel, C.; Singh, C.; Patel, V.; Kashif, M.; Borger, M.A.; Chakravarty, T.; et al. Commissural Alignment After Balloon-Expandable Transcatheter Aortic Valve Replacement Is Associated With Improved Hemodynamic Outcomes. JACC: Cardiovasc. Interv. 2022, 15, 1126–1136. [Google Scholar] [CrossRef]
- Nuis, R.J.; Yee, J.; Adrichem, R.; Hokken, T.W.; Lenzen, M.; Daemen, J.; de Jaegere, P.P.; Van Mieghem, N.M. Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve. EuroIntervention 2022. [Google Scholar] [CrossRef]
- Bing, R.; Deutsch, M.-A.; Sellers, S.L.; Corral, C.A.; Andrews, J.P.; van Beek, E.J.; Bleiziffer, S.; Burchert, W.; Clark, T.; Dey, D.; et al. 18F-GP1 Positron Emission Tomography and Bioprosthetic Aortic Valve Thrombus. JACC: Cardiovasc. Imaging 2022, 15, 1107–1120. [Google Scholar] [CrossRef]
- Andrade, D.; E Vinck, E.; Zuluaga, J.F. Valve-sparing thrombectomy for aortic-valve bio-prosthetic thrombosis. Asian Cardiovasc. Thorac. Ann. 2021, 30, 211–212. [Google Scholar] [CrossRef]
- Kambeitz, C.; Kemp, W. Thrombosis of Bioprosthetic Valve Associated With Acute Myocardial Injury. Am. J. Forensic Med. Pathol. 2020, 42, e59–e60. [Google Scholar] [CrossRef] [PubMed]
- Bartus, K.; Litwinowicz, R.; Bilewska, A.; Stapor, M.; Bochenek, M.; Rozanski, J.; Sadowski, J.; Filip, G.; Kusmierczyk, M.; Kapelak, B. Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis. Eur. J. Cardio-Thoracic Surg. 2021, 59, 434–441. [Google Scholar] [CrossRef]
- Leon, M.B.; Mack, M.J.; Hahn, R.T.; Thourani, V.H.; Makkar, R.; Kodali, S.K.; Alu, M.C.; Madhavan, M.V.; Chau, K.H.; Russo, M.; et al. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. J. Am. Coll. Cardiol. 2021, 77, 1149–1161. [Google Scholar] [CrossRef]
- Hattori, T.; Yoshida, R.; Yoshida, Y.; Akita, S.; Kato, W.; Tajima, K.; Murohara, T. A case of acute myocardial infarction caused by a giant thrombus derived from an aneurysm of the sinus of valsalva and a bioprosthetic aortic valve. J. Echocardiogr. 2020, 19, 181–182. [Google Scholar] [CrossRef]
- Landes, U.; Webb, J.G.; De Backer, O.; Sondergaard, L.; Abdel-Wahab, M.; Crusius, L.; Kim, W.-K.; Hamm, C.; Buzzatti, N.; Montorfano, M.; et al. Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction. J. Am. Coll. Cardiol. 2020, 75, 1882–1893. [Google Scholar] [CrossRef]
- A Chacon-Portillo, M.; Dhakal, B.; Janardhanan, R. Bioprosthetic aortic valve haemodynamic deterioration secondary to a thrombus. BMJ Case Rep. 2020, 13, e233400. [Google Scholar] [CrossRef]
- Petrescu, I.; Egbe, A.C.; Ionescu, F.; Nkomo, V.T.; Greason, K.L.; Pislaru, C.; Pellikka, P.A.; Connolly, H.M.; Pislaru, S.V. Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis. J. Am. Coll. Cardiol. 2020, 75, 857–866. [Google Scholar] [CrossRef]
- Abdel-Wahab, M.; Landt, M.; Neumann, F.-J.; Massberg, S.; Frerker, C.; Kurz, T.; Kaur, J.; Toelg, R.; Sachse, S.; Jochheim, D.; et al. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. JACC Cardiovasc. Interv. 2020, 13, 1071–1082. [Google Scholar] [CrossRef]
- Kealhofer, J.V.; Markowitz, J.S.; Nijjar, P.S. Use of Computed Tomography to Distinguish Thrombus from Pannus on a Bioprosthetic Aortic Valve. Tex. Hear. Inst. J. 2019, 46, 219–221. [Google Scholar] [CrossRef]
- Bamford, P.; Rogers, J.; Bassin, L.; Kull, A. Large Bioprosthetic Aortic Valve Thrombi on DOACs. Hear. Lung Circ. 2019, 28, e139–e142. [Google Scholar] [CrossRef]
- Balakrishnan, K.; Herman, B.; Koshy, G. Very late bioprosthetic aortic valve thrombosis. BMJ Case Rep. 2019, 12, e228871. [Google Scholar] [CrossRef]
- Leatherby, R.J.; Osman, M.; Birdi, I.; Serino, W. Early failure of a bioprosthetic aortic valve due to thrombus formation while on rivaroxaban. Eur. J. Cardio-Thoracic Surg. 2018, 55, 1231–1233. [Google Scholar] [CrossRef] [PubMed]
- Basra, S.S.; Gopal, A.; Hebeler, K.R.; Baumgarten, H.; Anderson, A.; Potluri, S.P.; Brinkman, W.T.; Szerlip, M.; Gopal, D.; Filardo, G.; et al. Clinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves by Four-Dimensional Computed Tomography. Ann. Thorac. Surg. 2018, 106, 1716–1725. [Google Scholar] [CrossRef]
- Franzone, A.; Pilgrim, T.; Haynes, A.G.; Lanz, J.; Asami, M.; Praz, F.; Räber, L.; Roost, E.; Langhammer, B.; Windecker, S.; et al. Transcatheter aortic valve thrombosis: Incidence, clinical presentation and long-term outcomes. Eur. Hear. J. Cardiovasc. Imaging 2017, 19, 398–404. [Google Scholar] [CrossRef]
- Fan, J.; Lipatov, K.; Lane, W.; Mixon, T. Management of bioprosthetic cardiac valve thrombosis. Bayl. Univ. Med Cent. Proc. 2018, 31, 496–498. [Google Scholar] [CrossRef] [PubMed]
- O'Callaghan, M.; Chester, R.; Scheckel, C.; Lee, J.Z.; Fernandes, R.; Shamoun, F. Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation. CASE 2018, 2, 54–58. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Vollema, E.M.; Kong, W.K.F.; Katsanos, S.; Kamperidis, V.; van Rosendael, P.; Van Der Kley, F.; De Weger, A.; Marsan, N.A.; Delgado, V.; Bax, J.J. Transcatheter aortic valve thrombosis: The relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke. Eur. Hear. J. 2017, 38, 1207–1217. [Google Scholar] [CrossRef]
- Couture, E.L.; Lepage, S.; Masson, J.-B.; Daneault, B. Very late transcatheter heart valve thrombosis. World J. Cardiol. 2017, 9, 196–199. [Google Scholar] [CrossRef]
- Dalén, M.; Sartipy, U.; Cederlund, K.; Franco-Cereceda, A.; Svensson, A.; Themudo, R.; Svenarud, P.; Brolin, E.B. Hypo-Attenuated Leaflet Thickening and Reduced Leaflet Motion in Sutureless Bioprosthetic Aortic Valves. J. Am. Hear. Assoc. 2017, 6, e005251. [Google Scholar] [CrossRef]
- Jose, J.; Sulimov, D.S.; El-Mawardy, M.; Sato, T.; Allali, A.; Holy, E.W.; Becker, B.; Landt, M.; Kebernik, J.; Schwarz, B.; et al. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes. JACC Cardiovasc. Interv. 2017, 10, 686–697. [Google Scholar] [CrossRef] [PubMed]
- Regazzoli, D.; Ancona, M.B.; Mangieri, A.; Agricola, E.; Spagnolo, P.; Mussardo, M.; Colombo, A.; Latib, A. A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis. JACC Cardiovasc. Interv. 2016, 9, e83–e84. [Google Scholar] [CrossRef] [PubMed]
- Del Trigo, M.; Muñoz-Garcia, A.J.; Wijeysundera, H.C.; Nombela-Franco, L.; Cheema, A.N.; Gutierrez, E.; Serra, V.; Kefer, J.; Amat-Santos, I.J.; Benitez, L.M.; et al. Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After Transcatheter Aortic Valve Replacement: Multicenter Registry. J. Am. Coll Cardiol. 2016, 67, 644–655. [Google Scholar] [CrossRef] [PubMed]
- Gałąska, R.; Kulawiak-Gałąska, D.; Fijałkowski, M.; Szurowska, E.; Gruchała, M. Multidetector computed tomography to detect reversible subclinical aortic bioprosthetic valve thrombosis with high systolic gradients. Cardiol. J. 2016, 23, 411–412. [Google Scholar] [CrossRef] [PubMed]
- Latib, A.; Naganuma, T.; Abdel-Wahab, M.; Danenberg, H.; Cota, L.; Barbanti, M.; Baumgartner, H.; Finkelstein, A.; Legrand, V.; de Lezo, J.S.; et al. Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis. Circ. Cardiovasc. Interv. 2015, 8, e001779. [Google Scholar] [CrossRef] [PubMed]
- Jander, N.; Sommer, H.; Pingpoh, C.; Kienzle, R.-P.; Martin, G.; Zeh, W.; Pache, G.; Siepe, M.; Beyersdorf, F.; Schumacher, M.; et al. The porcine valve type predicts obstructive thrombosis beyond the first three postoperative months in bioprostheses in the aortic position. Int. J. Cardiol. 2015, 199, 90–95. [Google Scholar] [CrossRef]
- Cremer, P.C.; Rodriguez, L.L.; Griffin, B.P.; Tan, C.D.; Rodriguez, E.R.; Johnston, D.R.; Pettersson, G.B.; Menon, V. Early Bioprosthetic Valve Failure: Mechanistic Insights via Correlation between Echocardiographic and Operative Findings. J. Am. Soc. Echocardiogr. 2015, 28, 1131–1148. [Google Scholar] [CrossRef] [PubMed]
- Orbach, A.; Karkabi, B.; Shiran, A. Reversible restenosis after transcatheter aortic valve implantation. Eur. Hear. J. Cardiovasc. Imaging 2013, 15, 350. [Google Scholar] [CrossRef] [PubMed]
- Brown, M.L.; Park, S.J.; Sundt, T.M.; Schaff, H.V. Early thrombosis risk in patients with biologic valves in the aortic position. J. Thorac. Cardiovasc. Surg. 2012, 144, 108–111. [Google Scholar] [CrossRef]
- Jander, N.; Kienzle, R.-P.; Kayser, G.; Neumann, F.-J.; Gohlke-Baerwolf, C.; Minners, J. Usefulness of Phenprocoumon for the Treatment of Obstructing Thrombus in Bioprostheses in the Aortic Valve Position. Am. J. Cardiol. 2011, 109, 257–262. [Google Scholar] [CrossRef]
- Peeceeyen, S.; Cao, C.; Fermanis, G.; Manganas, C. Early stenosis of Medtronic Mosaic bioprosthesis in the aortic position. J. Thorac. Cardiovasc. Surg. 2011, 143, e13–e14. [Google Scholar] [CrossRef]
- Achouh, P.; Jemel, A.; Chaudeurge, A.; Redheuil, A.; Zegdi, R.; Fabiani, J.-N. Aortic Biological Valve Thrombosis in an HIV Positive Patient. Ann. Thorac. Surg. 2011, 91, e90–e91. [Google Scholar] [CrossRef]
- Ohnaka, M.; Nishimura, K.; Kurokawa, S. Flat Fibrin Thrombus Deposition on Tissue Valve After Aortic Valve Replacement. Ann. Thorac. Surg. 2010, 89, 2032–2034. [Google Scholar] [CrossRef] [PubMed]
- Nishida, K.; Fukuyama, O. "Reversible" late bioprosthetic aortic valve stenosis with spontaneous recovery. Hawaii Med J. 2009, 68. [Google Scholar]
- Juliard, J.M.; Paillole, C.; Dahan, M.; Steg, P.G.; Himbert, D.; Aumont, M.C. Late thrombotic obstruction of an aortic bioprosthetic valve: Successful treatment by oral anticoagulation. Clin. Cardiol. 1993, 16, 152–154. [Google Scholar] [CrossRef] [PubMed]
- Collins, T.; Schoen, F.J.; Mudge, G.H.; Collins, J.J. Thrombosis associated with a porcine bioprosthesis and ascending aortic graft in a patient with the Marfan syndrome. J. Thorac. Cardiovasc. Surg. 1983, 85, 27–33. [Google Scholar] [CrossRef]
- Rafiq, S.; Steinbrüchel, D.A.; Lilleør, N.B.; Møller, C.H.; Lund, J.T.; Thiis, J.J.; Køber, L.; Olsen, P.S. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial. Thromb. Res. 2016, 150, 104–110. [Google Scholar] [CrossRef] [PubMed]
Timeline | 09/2007 | 11/2009 | 05/2011 | 10/2012 | 11/2013 | 04/2014 | 06/2014 | |
---|---|---|---|---|---|---|---|---|
MG (mmHg) | 43 | 37 | 50 | 43 | 46 | 48 | 6-week warfarin therapy | 14 |
Velocity (m/s) | 4.0 | 4.1 | 4.5 | 4.3 | 4.4 | 4.4 | 2.7 | |
LVEF (%) | 65 | 60 | 60 | 65 | 58 | 63 | 56 | |
Acceleration time (msec) | - | - | - | 113 | 139 | 140 | 114 | |
Aortic valve area (cm2) | - | - | 0.9 | 1 | 0.90 | 0.77 | 1.54 | |
Cardiac output (l/min) | - | - | - | - | 5.95 | 4.81 | 5.80 | |
Cardiac index (l/min/m2) | - | - | - | - | 2.73 | 2.24 | 2.71 | |
RV systolic pressure (mmHg) | 43 | 55 | 60 | 54 | 64 | 58 | 60 |
Reference | Number of Cases | Type of Valve Replacement (SAVI vs. TAVI) | Time from Valve Replacement to BAV Thrombosis Diagnosis (months) |
---|---|---|---|
Nuis et al. (2022) [17] | 8 | TAVI | Up to 60 months * |
Bing et al. (2022) [18] | 3 | TAVI and SAVI | 14–75 months |
Andrade et al. (2022) [19] | 1 | SAVI | 36 months |
Naser et al. (2022) [2] | 2 | SAVI | Up to 50 months * |
Naser et al. (2021) [5] | 32 | TAVI and SAVI | 12.4–65.9 months |
Kambeitz and Kemp (2021) [20] | 1 | SAVI | 24 months |
Bartus et al. (2021) [21] | 1 | SAVI | Less than 60 months * |
Leon et al. (2020) [22] | 16 | TAVI and SAVI | Beyond 24 months, but not précised |
Hattori et al. (2020) [23] | 1 | SAVI | 120 months |
Landes et al. (2020) [24] | 14 | TAVI | Beyond 12 months, but not précised |
Chacon-Portillo et al. (2020) [25] | 1 | SAVI | 24 months |
Petrescu et al. (2020) [26] | 62 | TAVI and SAVI | 9–68 months |
Abdel-Wahab et al. (2020) [27] | 3 | TAVI | Up to 60 months |
Kealhofer et al. (2019) [28] | 1 | SAVI | 24 months |
Bamford et al. (2019) [29] | 2 | SAVI | 72 and 84 months |
Balakrishnan et al. (2019) [30] | 1 | SAVI | 96 months |
Leatherby et al. (2019) [31] | 1 | SAVI | 24 months |
Egbe et al. (2018) [10] | 53 | TAVI and SAVI | 12–43 months * § (one case up to 9 years) |
Basra et al. (2018) [32] | 32 | TAVI and SAVI | 0.2–130.9 months |
Franzone et al (2018) [33] | 10 | TAVI | 1–17.2 months |
Fan et al. (2018) [34] | 3 | TAVI and SAVI | 4 to 78 months |
O’Callaghan et al. (2018) [35] | 1 | SAVI | 48 months |
Chakravarty et al. (2017) [7] | 106 | TAVI and SAVI | 1–14 months |
Egbe et al. (2017) [9] | 31 | TAVI and SAVI | 13–80 months * § |
Vollema et al. (2017) [36] | 16 | TAVI | Up to 36 months |
Couture et al. (2017) [37] | 1 | TAVI | 54 months |
Dalen et al. (2017) [38] | 31 | SAVI | 1–41 months |
Jose et al. (2017) [39] | 18 | TAVI | Up to 36 months |
Regazzoli et al. (2016) [40] | 1 | TAVI | 36 months |
Del Trigo et al. (2016) [41] | 68 | TAVI | Up to 35 months |
Galaska et al. (2016) [42] | 1 | SAVI | 15 months |
Egbe et al. (2015) [11] | 29 | TAVI and SAVI | 12–60 months * § |
Makkar et al. (2015) [8] | 39 | TAVI and SAVI | Up to 23 months |
Pislaru et al. (2015) [1] | 11 | SAVI | 1–47 months |
Latib et al. (2015) [43] | 26 | TAVI | Up to 24 months |
Jander et al. (2015) [44] | 17 | SAVI | Up to 21.1 months |
Cremer et al. (2015) [45] | 1 | SAVI | 36 months |
Orbach et al. (2013) [46] | 1 | TAVI | 21 months |
Brown et al. (2012) [47] | 8 | SAVI | 3.5–20.5 months |
Jander et al. (2012) [48] | 6 | SAVI | 8–14 months |
Peeceeyen et al. (2012) [49] | 2 | SAVI | 18 and 60 months |
Achouh et al. (2011) [50] | 1 | SAVI | 24 months |
Ohnaka et al. (2010) [51] | 1 | SAVI | 27 months |
Nishida et al. (2009) [52] | 1 | SAVI | 24 months |
Juliard et al. (1993) [53] | 1 | SAVI | 40 months |
Collins et al. (1983) [54] | 1 | SAVI | 29 months |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Radovanovic, M.; Nordstrom, C.W.; Hanna, R.D. Bioprosthetic Aortic Valve Thrombosis and Literature Review. J. Cardiovasc. Dev. Dis. 2022, 9, 252. https://doi.org/10.3390/jcdd9080252
Radovanovic M, Nordstrom CW, Hanna RD. Bioprosthetic Aortic Valve Thrombosis and Literature Review. Journal of Cardiovascular Development and Disease. 2022; 9(8):252. https://doi.org/10.3390/jcdd9080252
Chicago/Turabian StyleRadovanovic, Milan, Charles W. Nordstrom, and Richard D. Hanna. 2022. "Bioprosthetic Aortic Valve Thrombosis and Literature Review" Journal of Cardiovascular Development and Disease 9, no. 8: 252. https://doi.org/10.3390/jcdd9080252
APA StyleRadovanovic, M., Nordstrom, C. W., & Hanna, R. D. (2022). Bioprosthetic Aortic Valve Thrombosis and Literature Review. Journal of Cardiovascular Development and Disease, 9(8), 252. https://doi.org/10.3390/jcdd9080252